Patent applications published 14 July 2010

Published: 24-Aug-2010

Selected patent applications from the weekly European Patents Bulletin


  • Combretum laurifolium mart extract and methods of extracting and using extract
    Selvamedica 2205069*

  • N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors
    Merck Sharp &_Dohme 2205070*

  • Methods for treating pressure induced optical neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of Lingo-1 antagonists and TRKB_agonists
    Biogen Idec 2205071*

  • Methods for treating a variety of diseases and conditions, and compounds useful therefore
    The Salk Institute for Biological Studies 2205072*

  • Azacystidine analogues and uses thereof
    Mount Sinai School of Medicine; Clavis Pharma 2205073*

  • Meonomycin analogues, methods of synthesis and uses thereof
    President and Fellows of Harvard College 2205074*

  • Therapies of treating cancer using combinations of COX-2 inhibitors and aromatase inhibitors or combinations of COX-2 inhibitors and oestrogen receptor antagonists
    Tragara Pharmaceuticals 2205075*

  • Combination therapy for the treatment of cancer using COX-2 inhibitors and dual inhibitors of EGFR_[ERBB1] and HER-2 [ERBB2]
    Tragara Pharmaceuticals 2205076*

  • Therapies for treating cancer using combinations of COX-2 inhibitors and anti-HER2 (ERBB2) antibodies or COX-2 inhibitors and HER2 (ERBB2) receptor tyrosine kinase inhibitors
    Tragara Pharmaceuticals 2205077*

  • Production of moatin stereoisomers
    Cargill Inc 2205078*

  • N-substituted oxindoline derivatives as calcium channel blockers
    Merck Sharp &_Dohme 2205079*

  • Substituted aryl sulphone derivatives as calcium channel blockers
    Merck Sharp &_Dohme; Neuromed Pharmaceuticals 2205083*

  • 2-aryl or heteroaryl indole derivatives
    Merck Sharp &_Dohme 2205085*

  • Naphthalene-based inhibitors of anti-apoptotic proteins
    Burnham Institute for Medical Research 2205088*

  • Extrudable and extruded compsns for delivery of bioactive agents, method of making the same and method of using same
    Philip Morris Products 2205227*

  • Compounds and methods for pharmaceutical use
    Mintails 2205229*

  • Pharmaceutical compsns of 5-hydroxy-tryptophan and serotonin-enhancing compound
    NeuroSearch 2205231*

  • Galenical formulations of aliskiren
    Novartis 2205232*

  • Galenical formulations of aliskiren and valsartan
    Novartis 2205233*

  • Methods and compsns for treating retinol-related diseases
    Sirion Therapeutics 2205234*

  • Formulation to improve gastrointestinal function
    University of Florida Research Foundation 2205235*

  • Novel agents for treatment of ailments and dysfunctions
    Regain Biotechnology 2205236*

  • Methods for protecting the skin from radiation insults
    Johns Hopkins University 2205237*

  • Combination therapy related to serotonin dual action compounds
    H Lundbeck 2205238*

  • Pyrrolo [1,2-C] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
    Takeda Pharmaceutical 2205239*

  • Endocannabinoids for enhancing growth and development in infants
    Ariel-University Research and Develop-ment Company; Ben Gurion University of the Negev Research and Development Authority; Hadasit Medical Research Sciences and Development 2205240*

  • Polo-like kinase inhibitors
    Takeda Pharmaceutical Co 2205241*

  • Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
    Genentech; F_Hoffmann-La Roche 2205242*

  • Mast cell stabilisers in treatment of obesity
    The Brigham and Women’s Hospital 2205243*

  • Methods of administering N-9%-tert-nutyl-isoxazol-3-yl)-N’-[4-[7-(2-morpholin-4-yl-ethoxy)imidazo]2,1-B[1,3]-benzothiol-2-yl]-phenyl)-urea to treat proliferative disease
    Ambit Biosciences 2205244*

  • Therapeutic use of diaminophenothiazines
    Wista Laboratories 2205245*

  • Compsns comprising quinolone and methods for treating or controlling infections
    Bausch &_Lomb 2205246*

  • Inhibitor of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels
    Sanofi-Aventis 2205247*

  • Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
    Nicox 2205248

You may also like